TDAC
NASDAQTranslational Development Acquisition Corp.
IPO2025
Price$10.83+0.12 (+1.12%)
2026-07-162026-10-16
News · 26 weeks320%
2026-04-262026-10-18
Mix1190d
- Other7(64%)
- SEC Filings2(18%)
- Offering1(9%)
- Leadership1(9%)
Latest news
25 items- PRProLogium and Rimac Technology Advance Next-Generation EV Battery DevelopmentPARIS, Oct. 12, 2026 (GLOBE NEWSWIRE) -- ProLogium today announced progress in its collaboration with Rimac Technology on next-generation electric vehicle battery pack development. The companies signed a Memorandum of Understanding (MOU) in September 2025 to develop a next-generation battery platform and have completed a battery pack concept mockup, which will be displayed at the 2026 Paris Motor Show. The next phase will focus on developing a functional battery segment to establish a basis for testing the thermal management and cell-integration concepts and support battery pack applications in the battery electric vehicle (BEV) market. The collaboration combines ProLogium's next-genera
- PRProLogium Unveils DCN, Opening a “Third State” Electrolyte Universe at Paris Motor ShowProLogium unveils its Dynamic Coordination Network (DCN), introducing a third lithium-ion transport mechanism beyond conventional liquid and solid electrolytesProLogium, FEV and OPmobility showcase automotive battery modules and prototypes spanning diverse vehicle platformsFrom GWh-scale manufacturing footprint in Taiwan and the Dunkirk gigafactory in France to battery recycling, ProLogium advances an integrated approach to manufacturing and material circularity TAIPEI, Taiwan, Oct. 08, 2026 (GLOBE NEWSWIRE) -- ProLogium will unveil its next-generation Dynamic Coordination Network (DCN) electrolyte architecture at the 2026 Mondial de l’Auto Paris, introducing a third lithium-ion transpo
- PRMercedes-Benz and ProLogium have entered into a joint testing agreement, including a preliminary technology evaluation of ProLogium’s latest Gen4 Superfluidized All Inorganic Solid State Battery Cell TechnologyMercedes-Benz continues to drive solid-state battery technology, and has secured priority access to ProLogium’s latest Gen4 Superfluidized Inorganic Next-Generation Lithium Ceramic Battery (Gen 4 battery) cells.ProLogium’s Gen4 battery technology highlights an innovative next generation battery technology approach with balanced and promising characteristics, such as high energy density, cell safety and high rate capability.This testing scheme builds upon the nearly 10-year partnership between the two companies that has included Mercedes-Benz’s investing in ProLogium and joint technical development agreements. TAIPEI, Taiwan, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Mercedes-Benz AG and ProLogiu
- PRKyushu Electric Power Advances Strategic Investment in ProLogium, Deepening Collaboration in Next-Generation Batteries and Energy SectorTAOYUAN, Taiwan, Sept. 09, 2026 (GLOBE NEWSWIRE) -- ProLogium today announced a further deepening of its long-term strategic partnership with Kyushu Electric Power Co., Inc. (Kyushu Electric Power). Following ongoing collaboration across energy, next-generation batteries and related industrial fields, Kyushu Electric Power is now moving forward with a strategic investment in ProLogium, extending the relationship from industrial collaboration to strategic capital participation. Built on a long-standing foundation of cooperation and mutual trust, this deepening relationship further strengthens the strategic ties between the two companies and underscores their shared confidence in the long-te
- PRProLogium Appoints Antony Sheriff, CEO of Rimac Group, to Board of DirectorsTAIPEI, Taiwan, Aug. 24, 2026 (GLOBE NEWSWIRE) -- ProLogium, a global pioneer in innovating and manufacturing next-generation lithium ceramic batteries, announced today the appointment of Antony Sheriff, CEO of Rimac Group, to its board of directors, effective upon the closing of the previously announced business combination agreement with Translational Development Acquisition Corp. (NASDAQ:TDAC). Sheriff brings nearly four decades of leadership experience across the global automotive and advanced manufacturing industries, with a background spanning product commercialization, manufacturing scale-up, international operations and board governance. His appointment is intended to strengthen
- SECSEC Form SCHEDULE 13G filed by Translational Development Acquisition Corp.SCHEDULE 13G - Translational Development Acquisition Corp. (0001926599) (Subject)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Translational Development Acquisition Corp.SCHEDULE 13G/A - Translational Development Acquisition Corp. (0001926599) (Subject)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Translational Development Acquisition Corp.SCHEDULE 13G/A - Translational Development Acquisition Corp. (0001926599) (Subject)
- PRProLogium and Translational Development Acquisition Corp. Announce $50 Million Committed Primary Capital Investment to Support Proposed Business CombinationInvestment consists of $50 million of committed capital from existing investors of ProLogium at the previously announced pre-money valuation of ProLogium of approximately $3.8 billion Proceeds form part of the previously announced target financing to support ProLogium’s proposed business combination with TDACProLogium expects to use proceeds to support the continued scale-up of its next-generation lithium ceramic battery production and advance construction of its planned gigafactory in Dunkirk, France, supported by its subsidy package of up to €1.375 billion from the Government of the French Republic TAIPEI, Taiwan and NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) -- Prologium Holding Inc. ("P
- SECSEC Form 425 filed by Translational Development Acquisition Corp.425 - Translational Development Acquisition Corp. (0001926599) (Subject)
- SECTranslational Development Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits8-K - Translational Development Acquisition Corp. (0001926599) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Translational Development Acquisition Corp.SCHEDULE 13G/A - Translational Development Acquisition Corp. (0001926599) (Subject)
- SECTranslational Development Acquisition Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Translational Development Acquisition Corp. (0001926599) (Filer)
- PRTDAC Announces ProLogium's Filing of F-4 As Continuing Momentum Towards MergerNEW YORK, July 6, 2026 /PRNewswire/ -- Translational Development Acquisition Company (NYSE:TDAC) ( "TDAC") announced that ProLogium has filed their initial F-4 with the SEC driving the companies forward towards a successful execution of the de-SPAC transaction. This filing gives the SEC and investors at large a fuller view into the history of ProLogium and further supporting information into the merger transaction that was announced on May 27, 2026. Michael Hoffman, Chairman and CEO of TDAC, commented, "We continue to be tremendously excited to work with the ProLogium team on this transaction. We believe that this F-4 filing with the SEC will provide investors significant color into the comp
- SECSEC Form DEFA14A filed by Translational Development Acquisition Corp.DEFA14A - Translational Development Acquisition Corp. (0001926599) (Filer)
- SECSEC Form 425 filed by Translational Development Acquisition Corp.425 - Translational Development Acquisition Corp. (0001926599) (Subject)
- SECTranslational Development Acquisition Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Translational Development Acquisition Corp. (0001926599) (Filer)
- PRTDAC Announces Very Successful Share Redemption Results in Connection with Extension Vote85% of Shares are not Redeemed, resulting in TDAC maintaining $156.8mm in trust95% of the Shares Voted Were In Favor of the ExtensionThese Great Results Follow the Momentum of the May 27, 2026 announcement of TDAC's Entry into a Merger Agreement with PrologiumPrologium is a global leader in next generation lithium ceramic battery technology, moving into growth markets, including AI Data Centers, aerospace, robotics, defense and electric vehiclesNEW YORK, June 22, 2026 /PRNewswire/ -- Translational Development Acquisition Company (NYSE:TDAC) (the "Company" or "TDAC") announced the very successful results of the shareholder vote held on 6/17/26 regarding the proposed extension of the SPAC life
- SECTranslational Development Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits8-K - Translational Development Acquisition Corp. (0001926599) (Filer)
- SECTranslational Development Acquisition Corp. filed SEC Form 8-K: Unregistered Sales of Equity Securities8-K - Translational Development Acquisition Corp. (0001926599) (Filer)
- SECSEC Form SCHEDULE 13G filed by Translational Development Acquisition Corp.SCHEDULE 13G - Translational Development Acquisition Corp. (0001926599) (Subject)
- INSIDERSEC Form 4 filed by Chairman and CEO Hoffman Michael B4 - Translational Development Acquisition Corp. (0001926599) (Issuer)
- SECSEC Form DEFA14A filed by Translational Development Acquisition Corp.DEFA14A - Translational Development Acquisition Corp. (0001926599) (Filer)
- SECSEC Form DEF 14A filed by Translational Development Acquisition Corp.DEF 14A - Translational Development Acquisition Corp. (0001926599) (Filer)
- SECSEC Form 425 filed by Translational Development Acquisition Corp.425 - Translational Development Acquisition Corp. (0001926599) (Subject)
TDAC FAQ
5 questionsWhat does Translational Development Acquisition Corp. do?
Trident Acquisitions Corp. does not have significant operations. It intends to enter into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more target businesses primarily in the oil and gas or other natural resource sector. Trident Acquisitions Corp. was incorporated in 2016 and is headquartered in New York, New York.Where does TDAC stock trade?
Translational Development Acquisition Corp. (TDAC) is listed on NASDAQ.When did Translational Development Acquisition Corp. go public?
Translational Development Acquisition Corp. (TDAC) completed its IPO in 2025.What are analysts saying about TDAC?
Translational Development Acquisition Corp. has had 1 recent analyst action on file. The most recent action was from Northland Capital Markets: Outperform with a $1600.00 price target on 2021-09-21. Recent price targets cluster around $1600.00.How can I track TDAC on Quantisnow?
Quantisnow aggregates Translational Development Acquisition Corp.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow TDAC to receive live email and push alerts on every new disclosure.